Apr 18, 2016 10:00 AM

Author: Cancer Learning Center


Clinical trials for some cancer patients may be the last, best hope for survival.

A phase I trial is the first time a treatment is studied in people—usually a select number of patients who have not had success with other treatments. A rigorous process of approval takes place before doctors test these new therapies on patients for the first time.

Established in 2008, the Huntsman Cancer Institute (HCI) Center for Investigational Therapeutics streamlines the phase I trial process. Scientists test theories about new therapies, then develop and study these therapies in the lab. When a treatment looks promising, scientists may study it in a phase I clinical trial. The program’s long-term goal is developing new cancer drugs based on HCI genetic discoveries.

“Many of our oncologists and hematologists are involved in developing phase I clinical trials, and we are integrating molecular diagnostics in the treatment of trial patients,” said Sunil Sharma, MD, HCI Senior Director of Clinical Research.

“It’s incredibly rewarding to have this program,” he said. “This is unique to Utah, and we now have so many more options for patients.”

Learn more about clinical trials at HCI. 


Cancer Learning Center

Huntsman Cancer Institute
cancerinfo@hci.utah.edu

clinical trials cancer research

Sign Up for Weekly Health Updates

Get weekly emails of the latest news from HealthFeed.